...
首页> 外文期刊>Bulletin of the Korean Chemical Society >Preparation of Solid Dispersion of Everolimus in Gelueire 50/13 using Melt Granulation Technique for Enhanced Drug Release
【24h】

Preparation of Solid Dispersion of Everolimus in Gelueire 50/13 using Melt Granulation Technique for Enhanced Drug Release

机译:利用熔体造粒技术制备依维莫司在Gelueire 50/13中的固体分散体以增强药物释放

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Solid dispersion (SD) system of everolimus (EVR) with Gelueire 50/13 (Stearoyl polyoxyl-32 glycerides) was prepared using melt granulation technique with the aim of improving the physicochemical properties and dissolution rate. The solid state characterization using scanning electron microscopy and X-ray powder diffraction, indicated that the drug was homogeneously distributed in the surfactant carrier in a stable amorphous form. The dissolution rate of EVR from the optimized SD composed of the drug, Gelueire 50/13 and microcrystalline cellulose in a weight ratio of 1:5:10, was markedly rapid and higher than that from the drug powder and the market product (Afmitor~R, Novartis Pharmaceuticals) in all dissolution mediums tested from pH 3.0 to pH 6.8. The results of this study suggest that formulation of SD with Gelueire 50/13 using melt granulation procedure may be a simple and promising approach for improving the dissolution rate and oral absorption of the anti-cancer agent without the need for using an organic solvent.
机译:采用熔体造粒技术制备了依维莫司(EVR)与Gelueire 50/13(硬脂酰聚氧-32甘油酯)的固体分散体(SD)系统,目的是提高其理化性质和溶解速率。使用扫描电子显微镜和X射线粉末衍射的固态表征表明,药物以稳定的无定形形式均匀地分布在表面活性剂载体中。由药物,Gluueire 50/13和微晶纤维素(重量比为1:5:10)组成的优化SD的EVR溶出速率显着快速且高于药物粉和市售产品(Afmitor〜 R,Novartis Pharmaceuticals)在pH 3.0至pH 6.8的所有溶出介质中进行测试。这项研究的结果表明,使用熔体造粒程序用Gelueire 50/13配制SD可能是一种简单而有希望的方法,可以提高抗癌剂的溶解速度和口服吸收,而无需使用有机溶剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号